The interplay of long non-coding RNAs and MYC in cancer

Michael J Hamilton1, Matthew D Young1, Silvia Sauer1

  • 1Department of Biochemistry, University of California, Riverside, CA 92521, USA.

AIMS Biophysics
|April 15, 2016
PubMed

Insights

Long non-coding RNAs (lncRNAs) regulate gene expression and are key in cancer. The complex lncRNA-MYC network offers potential new cancer treatment strategies by targeting these interactions.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Research

Background:

  • Long non-coding RNAs (lncRNAs) were once considered non-functional but are now recognized as crucial epigenetic regulators in eukaryotic gene regulation.
  • Several lncRNAs play critical roles in cancer development and maintenance.
  • The oncogenic transcription factor MYC is implicated in most cancers, leading to research into its interactions with lncRNAs.

Purpose of the Study:

  • To review the current understanding of lncRNA roles in chromatin structure and gene transcription.
  • To focus on recent developments in the lncRNA-MYC network within the context of cancer.
  • To highlight the potential of targeting lncRNAs for novel cancer therapeutics.

Main Methods:

  • Review of existing literature on lncRNA function and epigenetic regulation.
  • Analysis of genome-wide studies on MYC's transcriptional regulation of lncRNAs.
  • Examination of studies identifying lncRNAs that regulate MYC expression.

Main Results:

  • MYC transcriptionally regulates numerous lncRNA genes.
  • Specific lncRNAs have been identified that regulate MYC expression at both transcriptional and post-transcriptional levels.
  • These interactions form a complex regulatory network with implications for cancer biology.

Conclusions:

  • lncRNAs are emerging as critical regulators of MYC oncogenic functions.
  • The lncRNA-MYC network presents a promising area for developing novel cancer treatment strategies.
  • Targeting lncRNAs could offer a new therapeutic avenue for various cancers.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K